Analysts Lift Targets on AbbVie, Flag Media Caution

Wall Street turned broadly constructive on Sunday, with target price upgrades dominating the latest analyst activity across healthcare, energy infrastructure, and real estate.

ABBV led the positive revisions. The pharma giant's consensus target rose to $273.86. AbbVie carries a near-$435 billion market cap and just 1.3% short interest — a stock bears have largely avoided.

ARE also received a target lift to $52.36. Alexandria Real Estate Equities, a life science-focused REIT, holds 5.2% short interest. The upgrade signal is notable given pressure the sector has faced this year.

WMB and AJG saw smaller but consistent upward target revisions. Williams Companies moved to $84.70. Arthur J. Gallagher climbed to $290.44, reflecting sustained analyst confidence in insurance brokers.

On the downside, PSKY — Paramount Skydance — saw its target trimmed to $9.81 from $10.12. Short interest sits near 9.7%, one of the higher readings in media. Analysts remain split: 7 buys versus 3 sells.

FIS also slipped, with Fidelity National Information Services' target cut to $51.09 from $52.45. The fintech firm faces 14 sell ratings against just one buy. That lopsided consensus warrants attention.